Cyteir Therapeutics Price History
CYTDelisted Stock | USD 2.76 0.01 0.36% |
If you're considering investing in Cyteir Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cyteir Therapeutics stands at 2.76, as last reported on the 20th of October, with the highest price reaching 2.81 and the lowest price hitting 2.75 during the day. We have found thirty technical indicators for Cyteir Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Cyteir Therapeutics' Downside Deviation of 3.55, mean deviation of 2.76, and Risk Adjusted Performance of 0.0909 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Cyteir Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cyteir |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
CYT |
Based on monthly moving average Cyteir Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cyteir Therapeutics by adding Cyteir Therapeutics to a well-diversified portfolio.
Cyteir Therapeutics Stock Price History Chart
There are several ways to analyze Cyteir Stock price data. The simplest method is using a basic Cyteir candlestick price chart, which shows Cyteir Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Cyteir Stock Price History Data
The price series of Cyteir Therapeutics for the period between Mon, Jul 22, 2024 and Sun, Oct 20, 2024 has a statistical range of 1.03 with a coefficient of variation of 12.44. The prices are distributed with arithmetic mean of 2.27. The median price for the last 90 days is 2.19. The company had 2:1 stock split on 18th of September 2014. Cyteir Therapeutics issued dividends on Nov 6, 2015.Open | High | Low | Close | Volume | ||
10/20/2024 | 2.75 | 2.81 | 2.75 | 2.76 | ||
07/21/2023 | 2.75 | 2.81 | 2.75 | 2.76 | 227,968 | |
07/20/2023 | 2.78 | 2.78 | 2.75 | 2.75 | 155,982 | |
07/19/2023 | 2.78 | 2.78 | 2.75 | 2.77 | 14,115 | |
07/18/2023 | 2.74 | 2.78 | 2.74 | 2.77 | 46,303 | |
07/17/2023 | 2.76 | 2.76 | 2.74 | 2.75 | 143,777 | |
07/14/2023 | 2.74 | 2.76 | 2.73 | 2.74 | 73,120 | |
07/13/2023 | 2.77 | 2.77 | 2.71 | 2.74 | 33,849 | |
07/12/2023 | 2.78 | 2.78 | 2.72 | 2.74 | 36,700 | |
07/11/2023 | 2.78 | 2.79 | 2.70 | 2.76 | 119,500 | |
07/10/2023 | 2.74 | 2.80 | 2.70 | 2.74 | 202,449 | |
07/07/2023 | 2.75 | 2.76 | 2.72 | 2.75 | 180,266 | |
07/06/2023 | 2.72 | 2.75 | 2.70 | 2.75 | 213,613 | |
07/05/2023 | 2.73 | 2.77 | 2.68 | 2.72 | 529,300 | |
07/03/2023 | 2.63 | 2.72 | 2.63 | 2.71 | 950,265 | |
06/30/2023 | 2.51 | 2.75 | 2.21 | 2.60 | 10,705,320 | |
06/29/2023 | 1.76 | 1.93 | 1.76 | 1.92 | 82,907 | |
06/28/2023 | 1.72 | 2.09 | 1.72 | 1.74 | 40,903 | |
06/27/2023 | 1.80 | 1.82 | 1.69 | 1.78 | 232,066 | |
06/26/2023 | 1.85 | 1.92 | 1.70 | 1.78 | 61,459 | |
06/23/2023 | 1.91 | 1.93 | 1.87 | 1.90 | 27,778 | |
06/22/2023 | 1.99 | 2.01 | 1.90 | 1.95 | 35,692 | |
06/21/2023 | 2.04 | 2.10 | 1.98 | 1.98 | 36,686 | |
06/20/2023 | 2.17 | 2.18 | 2.07 | 2.09 | 8,209 | |
06/16/2023 | 2.00 | 2.23 | 1.98 | 2.20 | 47,480 | |
06/15/2023 | 2.12 | 2.15 | 2.00 | 2.00 | 74,614 | |
06/14/2023 | 2.10 | 2.12 | 2.06 | 2.12 | 21,942 | |
06/13/2023 | 2.11 | 2.20 | 2.10 | 2.10 | 16,614 | |
06/12/2023 | 2.14 | 2.21 | 2.10 | 2.11 | 6,373 | |
06/09/2023 | 2.25 | 2.25 | 2.09 | 2.12 | 8,401 | |
06/08/2023 | 2.14 | 2.15 | 2.04 | 2.07 | 20,984 | |
06/07/2023 | 2.16 | 2.20 | 2.01 | 2.12 | 251,265 | |
06/06/2023 | 2.20 | 2.24 | 2.16 | 2.16 | 3,521 | |
06/05/2023 | 2.11 | 2.27 | 2.11 | 2.24 | 15,004 | |
06/02/2023 | 2.26 | 2.27 | 2.23 | 2.23 | 15,236 | |
06/01/2023 | 2.31 | 2.34 | 2.26 | 2.26 | 11,168 | |
05/31/2023 | 2.27 | 2.33 | 2.22 | 2.30 | 31,211 | |
05/30/2023 | 2.28 | 2.32 | 2.20 | 2.28 | 36,149 | |
05/26/2023 | 2.14 | 2.29 | 2.09 | 2.21 | 9,818 | |
05/25/2023 | 2.15 | 2.19 | 2.13 | 2.14 | 15,540 | |
05/24/2023 | 2.12 | 2.27 | 2.12 | 2.22 | 28,903 | |
05/23/2023 | 2.24 | 2.26 | 2.14 | 2.24 | 9,374 | |
05/22/2023 | 2.28 | 2.33 | 2.26 | 2.26 | 10,961 | |
05/19/2023 | 2.23 | 2.25 | 2.16 | 2.25 | 13,504 | |
05/18/2023 | 2.25 | 2.25 | 2.15 | 2.23 | 8,877 | |
05/17/2023 | 2.14 | 2.25 | 2.14 | 2.25 | 6,099 | |
05/16/2023 | 2.11 | 2.30 | 2.07 | 2.20 | 66,021 | |
05/15/2023 | 2.40 | 2.53 | 2.17 | 2.17 | 48,283 | |
05/12/2023 | 2.21 | 2.40 | 2.15 | 2.40 | 10,723 | |
05/11/2023 | 2.17 | 2.19 | 2.08 | 2.17 | 26,300 | |
05/10/2023 | 2.18 | 2.21 | 2.11 | 2.17 | 16,906 | |
05/09/2023 | 2.10 | 2.18 | 2.08 | 2.16 | 193,338 | |
05/08/2023 | 2.19 | 2.19 | 2.10 | 2.10 | 53,675 | |
05/05/2023 | 2.21 | 2.32 | 2.12 | 2.21 | 15,058 | |
05/04/2023 | 2.08 | 2.20 | 2.08 | 2.20 | 60,723 | |
05/03/2023 | 2.18 | 2.18 | 2.05 | 2.10 | 101,551 | |
05/02/2023 | 2.14 | 2.17 | 2.03 | 2.17 | 25,730 | |
05/01/2023 | 2.10 | 2.17 | 2.10 | 2.16 | 15,753 | |
04/28/2023 | 2.19 | 2.25 | 2.11 | 2.16 | 19,419 | |
04/27/2023 | 2.16 | 2.17 | 2.15 | 2.16 | 20,204 | |
04/26/2023 | 2.16 | 2.19 | 2.11 | 2.15 | 18,590 |
About Cyteir Therapeutics Stock history
Cyteir Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cyteir is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cyteir Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cyteir Therapeutics stock prices may prove useful in developing a viable investing in Cyteir Therapeutics
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. The company was incorporated in 2012 and is based in Lexington, Massachusetts. Cyteir Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.
Cyteir Therapeutics Stock Technical Analysis
Cyteir Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
All Next | Launch Module |
Cyteir Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cyteir Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cyteir Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cyteir to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0909 | |||
Jensen Alpha | 0.5834 | |||
Total Risk Alpha | (0.05) | |||
Sortino Ratio | 0.1349 | |||
Treynor Ratio | (2.83) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Cyteir Stock
If you are still planning to invest in Cyteir Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cyteir Therapeutics' history and understand the potential risks before investing.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies |